As part of our ongoing series here at The Acquirer’s Multiple, we provide this feature article titled ‘Stock in Focus‘ where we focus on one of the stocks from our Stock Screeners.
One of the cheapest stocks in our Stock Screeners is:
AbbVie Inc (ABBV)
AbbVie is a pharmaceutical firm with a strong exposure to immunology and oncology. The firm’s top drug, Humira, represents close to half of the company’s current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women’s health.
A quick look at the share price history (below) over the past twelve months shows that the price is down 5.51%. Here’s why the company is undervalued.
Market Cap: $250.31 Billion
Enterprise Value: $305.71 Billion
Operating Earnings: $23.30 Billion
Acquirer’s Multiple: 13.10
Free Cash Flow (TTM)
Free Cash Flow: $23.52 Billion
FCF/EV Yield %:
FCF/EV Yield: 9.40
Shareholder Yield %:
Shareholder Yield: 4.80
Piotroski F-Score: 5.00
Altman Z-Score: 2.104
ROA (5 Year Avge%): 17
For all the latest news and podcasts, join our free newsletter here.
Don’t forget to check out our FREE Large Cap 1000 – Stock Screener, here at The Acquirer’s Multiple: